期刊文献+

洛美利嗪对喹啉酸致海马神经元损伤的保护作用

Lomerizine protects the hippocampus neurons cultured in vitro from the injury caused by quinolinic acid
下载PDF
导出
摘要 目的:利用洛美利嗪(LOM)研究钙离子拮抗剂对兴奋性氨基酸喹啉酸(QA)所致体外培养海马神经元损伤是否有保护作用。方法:原代海马神经元与QA共同培养建立兴奋毒损伤细胞模型,观察1.2×10-6m o l/L,1.2×1-0 7m o l/L,1.2×10-8m o l/L 3个剂量LOM对培养神经元的形态学、乳酸脱氢酶(LDH)、细胞存活率的影响。结果:LOM可提高QA损伤的海马神经元细胞存活率,减少LDH释放,与模型组比较差异有显著性(P<0.01),并能减轻神经元的病理形态学损伤。结论:LOM对QA所致的海马神经元损伤有明显的保护作用,而QA所引起的兴奋毒性可能与C a2+超载所造成的链式损伤有关。 Objective:To study if Lomerizine (LOM) protects the hippocampus neurons cultured in vitro from the injury caused by quinolinic acid (QA). Methods:The model of neurons injured by QA was established by co-culturing hippocampus neurons with QA. The morphological change, LDH and cell survival rate were examined after adding LOM into the medium with concentrations at 1.2×10^-6mol/L,1.2×10^-7mol/L,1.2×10^-8mol/L. Results:LOM increased the survival rate of hippocampus neurons injured by QA, diminished the release of LDH and improved the pathological morphology, with significant difference from those of the control (P〈0.01). Conclusion:LOM could remarkably protect the hippocampus cells from the damage of QA.
出处 《广东医学院学报》 2006年第3期235-237,共3页 Journal of Guangdong Medical College
关键词 海马神经元 洛美利嗪 喹啉酸 hippocampus neurons Lomerizine quinolinic acid
  • 相关文献

参考文献10

  • 1VOLTERRA A,TROTTI D,TROMBA C.Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes[J].Neurosci,1994,14(5 pt 1):2924-2932.
  • 2徐俊,钱采韵.Alzheimer病的兴奋毒损伤机制[J].中国神经科学杂志,2000,16(4):379-382. 被引量:6
  • 3易永,杨祥良,徐辉碧.活性氧在谷氨酸兴奋性神经毒性中的作用[J].生命的化学,1997,17(6):28-30. 被引量:3
  • 4OKUN N,ITOH Y,ULCAI Y.Preferential inhibition by a novel Na^+/Ca^2+ channel blocker NS27 of severe to mild hypoxic injury in rat cerebral cortical slices:a possible involvement of a highly voltage-dependent blockade of Ca^2+ channel[J].J Pharmacol Exp Ther,2000,293(3):522-529.
  • 5LAFERLA F.Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease[J].Nat Rev Neurosci,2002,3 (11):862-872.
  • 6徐叔云 卞如廉.药理学实验方法[M].北京:人民卫生出版社,2002.1414.
  • 7LISY V,STASTNY F.Nitric oxide synthase inhibition and glutamate binding in quinolinate-lesioned rat hippocampus[J].Physiol Res,2002,51(3):299-307.
  • 8DU J,FENG L,YANG F,et al.Activity and Ca2+-dependent modulation of surface expression of brain derived neurotrophic factor receptors in hippocampal neurons[J].Cell Biol,2000,150:1423-1433.
  • 9KUROKI Y,FUKUSHIMA H,et al.Neuroprotection by estrogen via extracellular signal-regulated kinase against quinolinic acid-induced cell death in the rat hippocampus[J].Eur J Neurosci,2001,13(3):472-476.
  • 10HARA H,TORJU N,SHIMAZAWA M.Clinical potential of lomerizine,a Ca^2+ channel blocker as an anti-glaucoma drug:effects on ocular circulation and retinal neuronal damage[J].Cardiovasc Drug Rev,2004,22(3):199-214.

二级参考文献21

  • 1[1]Emilien G, Maloteaus JM, Beyreuther K, et al. Alzheimer disease: mouse models pave the way for therapeutic opportunity[J]. Arch Neurol, 2000, 57:176~181.
  • 2[2]Hollmann M, Heinemann S. Cloned glutamate receptora[J].Ann Rev Neurosci, 1994, 17:31~108.
  • 3[3]Tang YP, Shimizu E, Dube GR, et al. Genetic enhancement of learning and memory in mice[J]. Nature, 1999, 401:63~69.
  • 4[4]Gasic GP, Hollmann M. Molecular neurobiology of glutamate receptors[J]. Ann Rev Physiol, 1997, 54:507~536.
  • 5[5]Aronica E, Dickson DW, Kress Y, et al. Non-plaque dystrophic dendrites in Alzheimer hippocampus : a new pathological structure revealed by glutamate receptor immunocytochemistry[J]. Neuroscience, 1998, 82(4): 979~991.
  • 6[6]Ulas J, Cotman CW. Decreued expression of N-methyl-Daspartate receptor 1 messenger RNA in select regions of Alzheimer brain[J]. Neuroscience, 1997, 79(4): 973~982.
  • 7[7]Turner KM, Burgoyne RD, Morgan A. Protein phosphorylation and the regulation of synaptic membrane traffic [J].TINS, 1999, 22:459~464.
  • 8[8]Mattson MP. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatibes[J]. Physiol Rev. 1997. 77(4):1081~1132.
  • 9[9]Wahlund LO. Biological markers and diagnostic investigations in Alzheimer's disease [J ]. Acta Neurol Scand, 1996,165(s):85.
  • 10[10]Ulas IH, Wurtman RJ, et al. Metabotropic glutamate receptor agonists increased release of soluble amyloid precursor protein derivatives from rat brain cortical and hippocampal slices[J]. J Pharmacol Exp Ther, 1997, 281(1):149~154.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部